Biotech · Private company · Chicago, IL, US
Regenerative Medical Solutions, Inc.
Track this companyFree. Adds Regenerative Medical Solutions, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Development of a safer stem cell-based diabetes therapy via suicide gene-mediated ablation of proliferative cellsFiscal year 2026 · $872.1KNIH RePORTER 5R44DK133008-03 · fetched Nov 12, 2026
- Development of a safer stem cell-based diabetes therapy via suicide gene-mediated ablation of proliferative cellsFiscal year 2025 · $915.1KNIH RePORTER 2R44DK133008-02 · fetched Nov 12, 2026